Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS)

Historical Holders from Q1 2020 to Q1 2025

Symbol
ANVS on NYSE
CUSIP
03615A108
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
19.6M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
1.58M
Holdings value
$7.92M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
40
Number of buys
19
Number of sells
-11
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CVI Investments, Inc. 5.1% $1.6M 1M CVI Investments, Inc. Feb 3, 2025

Institutional Holders of Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 98.2K $147K -$1.05K $1.50 2
2024 Q4 1.58M $7.92M +$1.71M $5.03 40
2024 Q3 1.18M $9.5M +$1.92M $8.06 38
2024 Q2 984K $5.67M -$2.07M $5.76 38
2024 Q1 1.19M $14.2M -$473K $11.90 39
2023 Q4 1.2M $22.5M +$2.42M $18.70 35
2023 Q3 1.11M $10.6M -$1.63M $9.49 28
2023 Q2 1.28M $18.3M +$7.34M $14.29 27
2023 Q1 752K $11.6M +$249K $15.41 22
2022 Q4 736K $9.89M +$230K $13.43 21
2022 Q3 710K $9.73M -$399K $13.70 19
2022 Q2 770K $8.74M -$1.47M $11.33 24
2022 Q1 889K $11.9M -$3.71M $13.35 22
2021 Q4 1.1M $19.3M -$2.54M $17.58 27
2021 Q3 1.14M $36.2M -$25M $31.74 36
2021 Q2 1.27M $109M +$32.2M $85.59 56
2021 Q1 687K $19M -$1.23M $27.90 28
2020 Q4 760K $5.73M +$93.8K $7.55 12
2020 Q3 316K $1.52M +$388K $4.81 11
2020 Q2 244K $1.06M +$222K $4.35 8
2020 Q1 193K $579K +$579K $3.01 5